Yu Lin
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
Papers in
- Surgery 31
- Esophageal Cancer Research and Treatment 18
- Esophageal and GI Pathology 10
- Congenital gastrointestinal and neural anomalies 7
- Intestinal Malrotation and Obstruction Disorders 4
-
- Lung Cancer Diagnosis and Treatment 9
- Gastric Cancer Management and Outcomes 9
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Junqiang Chen (16 shared papers)Jianji Pan (5 shared papers)Xia Qin (1 shared paper)Jian Zhang (1 shared paper)Jianing Zhang (1 shared paper)Zhiqiang Cheng (1 shared paper)Anouchka Coste (2 shared papers)Mingqiu Chen (4 shared papers)
- Journals
- BMC Surgery (3 papers)Radiation Oncology (2 papers)BMC Cancer (2 papers)Frontiers in Oncology (2 papers)Clinical & Translational Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yu Lin
38 papers receiving 431 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 128
- Pulmonary and Respiratory Medicine 157
- Surgery 203
- Oncology 122
- Molecular Biology 146
Countries citing papers authored by Yu Lin
This map shows the geographic impact of Yu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lin more than expected).
Fields of papers citing papers by Yu Lin
This network shows the impact of papers produced by Yu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lin. The network helps show where Yu Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 91 | |
| 2 | 2018 | 45 | |
| 3 | 2020 | 44 | |
| 4 | 2018 | 26 | |
| 5 | 2018 | 20 | |
| 6 | 2014 | 18 | |
| 7 | 2020 | 17 | |
| 8 | 2019 | 16 | |
| 9 | 2017 | 16 | |
| 10 | 2017 | 16 | |
| 11 | 2015 | 10 | |
| 12 | 2019 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2019 | 5 |
About Yu Lin
Yu Lin is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 39 papers that have together received 435 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (18 papers), Esophageal and GI Pathology (10 papers), Lung Cancer Diagnosis and Treatment (9 papers), Gastric Cancer Management and Outcomes (9 papers), Congenital gastrointestinal and neural anomalies (7 papers), Colorectal Cancer Surgical Treatments (5 papers), Intestinal Malrotation and Obstruction Disorders (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (128 citations), Pulmonary and Respiratory Medicine (157 citations), Surgery (203 citations), Oncology (122 citations) and Molecular Biology (146 citations). Yu Lin has collaborated with scholars based in China and United States. Frequent co-authors include Junqiang Chen, Jianji Pan, Xia Qin, Jian Zhang, Jianing Zhang, Zhiqiang Cheng, Anouchka Coste, Mingqiu Chen, Yarong Wang and Minmin Shen. Their work appears in journals such as BMC Surgery, Radiation Oncology, BMC Cancer, Frontiers in Oncology and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.